2022
DOI: 10.1016/s0140-6736(21)02759-8
|View full text |Cite
|
Sign up to set email alerts
|

Racialised people in clinical guideline panels

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
15
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(23 citation statements)
references
References 7 publications
0
15
0
1
Order By: Relevance
“…Antimicrobial resistance (AMR) is a global problem, but this systematic analysis of the burden in 204 countries is the most comprehensive yet in estimating the distribution of and the leading pathogen-drug combinations causing AMR. 1 The authors found that 4.95 million deaths (95% confidence interval (CI) 3.62-6.57) were associated with AMR in 2019, of which they determined 1.27 million deaths (95% CI 0.91-1.71) were caused by AMR. The death rate was highest in western Sub-Saharan Africa at 27.3 deaths per 100 000 (20.9-35.3) and lowest in Australasia at 6.5 deaths (4.3-9.4) per 100 000 (Fig.…”
Section: Global Burden Of Antimicrobial Resistancementioning
confidence: 99%
“…Antimicrobial resistance (AMR) is a global problem, but this systematic analysis of the burden in 204 countries is the most comprehensive yet in estimating the distribution of and the leading pathogen-drug combinations causing AMR. 1 The authors found that 4.95 million deaths (95% confidence interval (CI) 3.62-6.57) were associated with AMR in 2019, of which they determined 1.27 million deaths (95% CI 0.91-1.71) were caused by AMR. The death rate was highest in western Sub-Saharan Africa at 27.3 deaths per 100 000 (20.9-35.3) and lowest in Australasia at 6.5 deaths (4.3-9.4) per 100 000 (Fig.…”
Section: Global Burden Of Antimicrobial Resistancementioning
confidence: 99%
“…How many of us sitting on a panel writing clinical practice guidelines have paused to consider the composition of the panel, the balance of women and men, non‐white and white? Canadian researchers 1 argue that ‘guideline panels should comprise individuals positioned to make relevant recommendations, including those that reflect the diversity of the priority population’. They analysed all 237 clinical practice guidelines published in national general medical journals from Australia, Canada, the UK and the USA between June 2014 and June 2021.…”
Section: Figmentioning
confidence: 99%
“…European researchers randomised 74 children aged 1-7 years, mean 5.6 (standard deviation = 1.6) years, to receive insulin via either a closed-loop system or sensoraugmented pump therapy (control) for 16 weeks; they then crossed over to the other treatment for 16 weeks in a multicentre, randomised, cross-over trial. 1 The closed-loop period was significantly superior to standard pump therapy in terms of time with glucose levels in the target range (72 vs. 63%, P < 0.001, which equated to a clinically significant 125 min/day), time spent in a hyperglycaemic state, difference in glycated haemoglobin level and difference in mean sensor glucose level (Fig. 1).…”
mentioning
confidence: 94%
“…Despite initiatives to advance the inclusion of women and members of historically marginalized groups in academic medicine and biomedical research, gender and racial inequities remain 1. Inequities are recognized in compensation, senior leadership positions, highly cited research publications, and professional society awards 234.…”
Section: Introductionmentioning
confidence: 99%